Literature DB >> 25304898

Synthesis and biological evaluation of a novel class of coumarin derivatives.

Hong Li1, Xiaomin Wang2, Guichao Xu1, Li Zeng1, Kai Cheng1, Pengchao Gao3, Qing Sun1, Wei Liao1, Jianwei Zhang4.   

Abstract

In this study, several novel coumarin derivatives, 7-hydroxy-2-oxo-2H-chromene-3-carboxyl-Trp-Trp-AA-OBzl compounds, were designed and synthesized as potential anticancer agents. Their in vitro cytotoxic activities were evaluated using methylthiazoltetrazolium (MTT) assay. The anti-tumor activity of the newly coumarin derivatives was determined in a S180 bearing mouse model and some of the compounds demonstrated tumor growth inhibition similar to the positive control, doxorubicin. Compared to doxorubicin, most of the compounds exhibited enhanced immunologic function suggesting a relatively minor toxic effect. The intercalation of the coumarin derivatives synthesized with calf thymus (CT) DNA was also studied.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Amino acid; Anti-tumor; Coumarin; Cytotoxicity; Peptide

Mesh:

Substances:

Year:  2014        PMID: 25304898     DOI: 10.1016/j.bmcl.2014.09.051

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  3 in total

1.  Antiproliferative Constituents of Geopropolis from the Bee Melipona scutellaris.

Authors:  Marcos Guilherme da Cunha; Pedro Luiz Rosalen; Marcelo Franchin; Severino Matias de Alencar; Masaharu Ikegaki; Tanya Ransom; John Albert Beutler
Journal:  Planta Med       Date:  2015-11-06       Impact factor: 3.352

2.  A Novel Fluorescent Probe for Hydrogen Peroxide and Its Application in Bio-Imaging.

Authors:  Yingying Zuo; Yang Jiao; Chunming Ma; Chunying Duan
Journal:  Molecules       Date:  2021-06-02       Impact factor: 4.411

3.  Microwave-assisted synthesis and antitumor evaluation of a new series of thiazolylcoumarin derivatives.

Authors:  Moustafa T Gabr; Nadia S El-Gohary; Eman R El-Bendary; Mohamed M El-Kerdawy; Nanting Ni
Journal:  EXCLI J       Date:  2017-08-30       Impact factor: 4.068

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.